Certara
drug approvals using | Certara
Company
Deck Type
Sector
Industry
Deck date
December 2021
Slide
20 of 91
Related slides by other companies
MAIA Biotechnology
Investor Presentation
January 2024
investment overview an | MAIA Biotechnology
BenevolentAI
Investor Day
September 2022
benevolent a validated approach internal pipeline validation strategic validation clinical regulatory validation pipeline generated from the benevolent platform one asset in phase assets in and named platform generated drug programmes exploratory stage programmes successful delivery on target long term collaboration us drug approved the benevolent successfully discovered an approved treatment for covid chronic kidney disease disease agnostic idiopathic pulmonary heart failure systemic lupus | BenevolentAI
Kymera
Investor Day
December 2021
exponential clinical pipeline growth of degraders targeted protein degradation | Kymera
Other recent decks by Certara
See all presentations (2 decks)
Investor Presentation
May 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights